Vanda Pharmaceuticals
VNDA
VNDA
158 hedge funds and large institutions have $562M invested in Vanda Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 59 increasing their positions, 50 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
35% less capital invested
Capital invested by funds: $867M → $562M (-$306M)
47% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 43
86% less call options, than puts
Call options by funds: $311K | Put options by funds: $2.27M
Holders
158
Holding in Top 10
1
Calls
$311K
Puts
$2.27M
Top Buyers
| 1 | +$18M | |
| 2 | +$7.47M | |
| 3 | +$5.21M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.59M |
| 5 |
Renaissance Technologies
New York
|
+$4.11M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$7.27M | |
| 3 | -$4.24M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$4.19M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$4.13M |